Biosimilars A New Generation of Biologics /
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular co...
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
---|---|
Άλλοι συγγραφείς: | Prugnaud, Jean-Louis (Επιμελητής έκδοσης), Trouvin, Jean-Hugues (Επιμελητής έκδοσης) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Paris :
Springer Paris : Imprint: Springer,
2013.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases
Έκδοση: (2017) -
The New Drug Reimbursement Game A Regulator’s Guide to Playing and Winning /
ανά: Pekarsky, Brita A.K
Έκδοση: (2015) -
Biosimilars Regulatory, Clinical, and Biopharmaceutical Development /
Έκδοση: (2018) -
Drug Interactions in Infectious Diseases
Έκδοση: (2011) -
From Molecular to Modular Tumor Therapy Tumors are Reconstructible Communicatively Evolving Systems /
Έκδοση: (2010)